Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
2002 6
2003 5
2004 6
2005 12
2006 15
2007 11
2008 18
2009 22
2010 24
2011 26
2012 24
2013 33
2014 34
2015 26
2016 23
2017 25
2018 30
2019 20
2020 25
2021 33
2022 21
2023 19
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

388 results

Results by year

Filters applied: . Clear all
Page 1
Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study.
Menzies-Gow A, Wechsler ME, Brightling CE, Korn S, Corren J, Israel E, Chupp G, Bednarczyk A, Ponnarambil S, Caveney S, Almqvist G, Gołąbek M, Simonsson L, Lawson K, Bowen K, Colice G; DESTINATION study investigators. Menzies-Gow A, et al. Lancet Respir Med. 2023 May;11(5):425-438. doi: 10.1016/S2213-2600(22)00492-1. Epub 2023 Jan 23. Lancet Respir Med. 2023. PMID: 36702146 Clinical Trial.
Treatable traits in the NOVELTY study.
Agustí A, Rapsomaniki E, Beasley R, Hughes R, Müllerová H, Papi A, Pavord ID, van den Berge M, Faner R; NOVELTY Study Investigators. Agustí A, et al. Respirology. 2022 Nov;27(11):929-940. doi: 10.1111/resp.14325. Epub 2022 Jul 21. Respirology. 2022. PMID: 35861464 Free PMC article.
Standards for practical intravenous rapid drug desensitization & delabeling: A WAO committee statement.
Alvarez-Cuesta E, Madrigal-Burgaleta R, Broyles AD, Cuesta-Herranz J, Guzman-Melendez MA, Maciag MC, Phillips EJ, Trubiano JA, Wong JT, Ansotegui I; Steering Committee Authors; Review Panel Members. Alvarez-Cuesta E, et al. World Allergy Organ J. 2022 May 31;15(6):100640. doi: 10.1016/j.waojou.2022.100640. eCollection 2022 Jun. World Allergy Organ J. 2022. PMID: 35694005 Free PMC article. Review.
APAAACI's activities and this issue.
Chang YS. Chang YS. Asia Pac Allergy. 2022 Jul 29;12(3):e33. doi: 10.5415/apallergy.2022.12.e33. eCollection 2022 Jul. Asia Pac Allergy. 2022. PMID: 35966162 Free PMC article. No abstract available.
COVID-19 and allergy.
Chang YS. Chang YS. Asia Pac Allergy. 2020 Jul 30;10(3):e34. doi: 10.5415/apallergy.2020.10.e34. eCollection 2020 Jul. Asia Pac Allergy. 2020. PMID: 32789119 Free PMC article. No abstract available.
Spring and allergy.
Chang YS. Chang YS. Asia Pac Allergy. 2018 Apr 30;8(2):e22. doi: 10.5415/apallergy.2018.8.e22. eCollection 2018 Apr. Asia Pac Allergy. 2018. PMID: 29732298 Free PMC article. No abstract available.
Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials.
Maurer M, Ensina LF, Gimenez-Arnau AM, Sussman G, Hide M, Saini S, Grattan C, Fomina D, Rigopoulos D, Berard F, Canonica GW, Rockmann H, Irani C, Szepietowski JC, Leflein J, Bernstein JA, Peter JG, Kulthanan K, Godse K, Ardusso L, Ukhanova O, Staubach P, Sinclair R, Gogate S, Thomsen SF, Tanus T, Ye YM, Burciu A, Barve A, Modi D, Scosyrev E, Hua E, Letzelter K, Varanasi V, Patekar M, Severin T; PEARL-1 and PEARL-2 trial investigators. Maurer M, et al. Lancet. 2024 Jan 13;403(10422):147-159. doi: 10.1016/S0140-6736(23)01684-7. Epub 2023 Nov 23. Lancet. 2024. PMID: 38008109 Clinical Trial.
Chronic cough in the elderly.
Song WJ, Won HK, An J, Kang SY, Jo EJ, Chang YS, Lee BJ, Cho SH. Song WJ, et al. Among authors: chang ys. Pulm Pharmacol Ther. 2019 Jun;56:63-68. doi: 10.1016/j.pupt.2019.03.010. Epub 2019 Mar 23. Pulm Pharmacol Ther. 2019. PMID: 30914319 Review.
Epithelial Barrier Theory: The Role of Exposome, Microbiome, and Barrier Function in Allergic Diseases.
Losol P, Sokolowska M, Hwang YK, Ogulur I, Mitamura Y, Yazici D, Pat Y, Radzikowska U, Ardicli S, Yoon JE, Choi JP, Kim SH, van de Veen W, Akdis M, Chang YS, Akdis CA. Losol P, et al. Among authors: chang ys. Allergy Asthma Immunol Res. 2023 Nov;15(6):705-724. doi: 10.4168/aair.2023.15.6.705. Allergy Asthma Immunol Res. 2023. PMID: 37957791 Free PMC article. Review.
388 results